NCT06457503 2026-04-06
TRANSPARENT
Coherus Oncology, Inc.
Phase 4 Recruiting
Clinical Trials
9 trialsNCT06423235 2026-03-24
ESPTTN
Xintian Pharmaceutical
Phase 4 Recruiting
NCT06162377 2025-12-17
Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
M.D. Anderson Cancer Center
Phase 4 Recruiting
NCT04265430 2025-11-14
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
M.D. Anderson Cancer Center
Phase 4 Recruiting
NCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT07189897 2025-10-08
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
State University of New York - Upstate Medical University
Phase 4 Recruiting
NCT06195228 2025-08-14
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Fudan University
Phase 4 Recruiting
NCT06169735 2025-05-06
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
University of Alabama at Birmingham
Phase 4 Recruiting
NCT06734598 2024-12-16
Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy
National Taiwan University Hospital
Phase 4 Recruiting